Diclofenac reduces the risk of Alzheimer’s disease: a pilot analysis of NSAIDs in two US veteran populations

BACKGROUND: Our aim was to determine whether specific nonsteroidal anti-inflammatory (NSAID) agents are associated with a decreased frequency of Alzheimer’s disease (AD). MATERIALS AND METHODS: Days of drug exposure were determined for diclofenac, etodolac, and naproxen using US Department of Vetera...

Descripción completa

Detalles Bibliográficos
Autores principales: Stuve, Olaf, Weideman, Rick A., McMahan, Danni M., Jacob, David A., Little, Bertis B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325551/
https://www.ncbi.nlm.nih.gov/pubmed/32647537
http://dx.doi.org/10.1177/1756286420935676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325551/
https://www.ncbi.nlm.nih.gov/pubmed/32647537
http://dx.doi.org/10.1177/1756286420935676

Ejemplares similares